SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Phoenix Molecular’s Seed Funding Reaches $12 Million

Co. Targets RSK2 Enzyme Often Found in Breast CancersPhoenix Molecular Designs is attacking advanced breast cancer in a new way — and with added funding.

Co.’s Concierge Care Takes On Tough Cases

MEDICINE: Focus Put on Population of Chronic Users

Just 5% of patients account for roughly half of the nation’s health care spending. These “super users” cycle through emergency rooms.

Neurocrine Pays $50 Million for Epilepsy Drug Candidate

PHARMA: Xenon Could Receive up to $1.7 Billion In Milestone Payments

Neurocrine Biosciences has plunked down $50 million upfront for a potential epilepsy treatment, the San Diego company’s second major licensing deal this year.

Evofem’s Gel Shows Promise Preventing Some STDs

Evofem Biosciences’ gel in midstage clinical trials reduced the risk of chlamydia and gonorrhea infections compared to a placebo.

Potential $31 Million Deal Shows Canale’s Work Paid Off

UGD Aims to Expand Footprint, Especially in West Coast

Carin Canale-Theakston founded Canale Communications. Her twin goals: build the largest life sciences communications firm on the West Coast.

Evofem’s Gel Lessens Risk of Chlamydia, Gonorrhea in Clinical Trial

Evofem Biosciences’ gel in mid-stage clinical trials reduced the risk of chlamydia and gonorrhea infections compared to a placebo, the San Diego company reported Dec. 2.

Avidity Gets $100M For Research Into Muscle Disorders

More Than a Dozen Entities Invest in Preclinical Programs

Avidity Biosciences recently was awarded a $100 million series C round.

Truvian Seeks to Decentralize Blood Testing

BIOTECH: Co. Aims for Transparency in Each Step

Truvian Sciences wants to run a battery of tests on only drops of blood. Its mobile lab is designed to return answers in 20 minutes.

Radys Pledge $200M to Children’s Hospital

PHILANTHROPY: Gift For Expansion and Integrating Care and Tech

Rady Children’s Hospital in San Diego recently announced the single largest donation in its history.

Neurocrine Shells Out $50M for Epilepsy Drug Candidate

Neurocrine Biosciences has plunked down $50 million upfront for a potential epilepsy treatment, the San Diego company’s second major licensing deal this year.

Vivid Genomics Helps Drug Developers Design Better Trials

MEDICINE: Co. Sees Opportunity in Precision Medicine for Alzheimer's

Biogen’s plans to resurrect its failed Alzheimer’s drug sent shockwaves through the research community, including at local companies.

Canale Communications Acquired in Deal Worth up to $31M

UGD Healthcare bought Canale Communications, a San Diego firm that specializes in strategy consulting for life sciences companies, it was announced Nov. 26.

Presidium Health Raises $3.5 Million To Reduce ER Visits

Co. Has Launched A Mobile Health Team In San Diego

Seniors and patients with chronic conditions are more likely to cycle through emergency rooms.

It’s Mirati Vs. Amgen As Drugmakers Target Mutated Gene

Bigger Sample Size, More Time Needed To Evaluate Drugs

An experimental drug from Mirati Therapeutics shrunk the tumors of some cancer patients with a common mutation, in an early-stage clinical trial.

Rady Children’s to Receive $200M Donation